Cerebain Biotech Has Made a Capital Investment in Diabetes Reversal Group, LLC
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has made a capital investment in Diabetes Reversal Group, LLC.
Cerebain Biotech Closes Share Exchange Agreement With PKG, Inc.
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has closed the Share Exchange Agreement with PKG, Inc. (PKG) thereby having total control and ownership...
Cerebain Biotech Provides Update on Share Exchange Agreement With PKG, Inc.
Cerebain Biotech Corp. (OTC: CBBT) (the “Company” or “Cerebain”) today provided an update pertaining to the Share Exchange Agreement with PKG, Inc., an Idaho Corporation (PKG) and the equity holders...
Cerebain Biotech Announces PKG, Inc. to Become Key Manufacturer for ClearMask™ and Xometry
Cerebain Biotech Corp. (OTC: CBBT), today announced that PKG, Inc. is to become the key manufacturer for ClearMask, LLC and Xometry.